33 research outputs found

    Gastroduodenal Mucosal Injury and Antiplatelet Drug Users

    Get PDF
    Antiplatelet drugs are widely used for the prevention of cardiovascular disease and cerebral vascular disorders. Although there have been several studies on gastroduodenal mucosal injury with gastrointestinal (GI) symptoms such as GI bleeding, in antiplatelet drug users (including low-dose aspirin (LDA)), there have been few reports on the association between antiplatelet drug use and gastroduodenal mucosal injury in asymptomatic antiplatelet drug users. This study was a cross-sectional study elucidating the association between antiplatelet drug use and gastroduodenal mucosal injury in asymptomatic antiplatelet drug users. Subjects were 186 asymptomatic Japanese antiplatelet drug users who underwent a regular health checkup. Subjects were divided into those with and without gastroduodenal mucosal injury endoscopically, and the association between gastroduodenal mucosal injury and other data in asymptomatic antiplatelet drug users was investigated. The prevalence of males and drinkers were significantly higher in subjects with gastroduodenal mucosal injury than in those without. In addition, the prevalence of proton pump inhibitor (PPI) users was significantly lower in subjects with gastroduodenal mucosal injury than in subjects without gastroduodenal mucosal injury. Logistic regression analysis showed PPI (odds ratios: 0.116; 95% confidence intervals: 0.021–0.638; P < 0.05) was a significant predictor of a decreased prevalence of gastroduodenal mucosal injury and closed-type (C-type) atrophy (3.172; 1.322–7.609; P < 0.01) was a significant predictor of an increased prevalence of severe gastroduodenal mucosal injury in asymptomatic antiplatelet drug users. Gender and lifestyle, such as drinking, may have an impact on risk of gastroduodenal mucosal injury in asymptomatic subjects taking antiplatelet drugs. Although PPI is a significant predictor of a decreased prevalence of gastroduodenal mucosal injury, including in asymptomatic antiplatelet drug users, status of gastric atrophy should also be considered against severe gastroduodenal mucosal injury

    Feasibility of Endoscopy-Assisted Laparoscopic Full-Thickness Resection for Superficial Duodenal Neoplasms

    Get PDF
    Background. Superficial duodenal neoplasms (SDNs) are a challenging target in the digestive tract. Surgical resection is invasive, and it is difficult to determine the site and extent of the lesion from outside the intestine and resect it locally. Endoscopic submucosal dissection (ESD) has scarcely been utilized in the treatment of duodenal tumors because of technical difficulties and possible delayed perforation due to the action of digestive juices. Thus, no standard treatments for SDNs have been established. To challenge this issue, we elaborated endoscopy-assisted laparoscopic full-thickness resection (EALFTR) and analyzed its feasibility and safety. Methods. Twenty-four SDNs in 22 consecutive patients treated by EALFTR between January 2011 and July 2012 were analyzed retrospectively. Results. All lesions were removed en bloc. The lateral and vertical margins of the specimens were negative for tumor cells in all cases. The mean sizes of the resected specimens and lesions were 28.9 mm (SD ± 10.5) and 13.3 mm (SD ± 11.6), respectively. The mean operation time and intraoperative estimated blood loss were 133 min (SD ± 45.2) and 16 ml (SD ± 21.1), respectively. Anastomotic leakage occurred in three patients (13.6%) postoperatively, but all were minor leakage and recovered conservatively. Anastomotic stenosis or bleeding did not occur. Conclusions. EALFTR can be a safe and minimally invasive treatment option for SDNs. However, the number of cases in this study was small, and further accumulations of cases and investigation are necessary

    顎顔面形態別の最大咬合力に対するガム咀嚼訓練の効果

    Get PDF
    Development of the masticatory system is influenced by functional needs. Furthermore, masticatory exercise can improve masticatory function. The aim of this study was to evaluate the potential effect of the gum chewing exercise on the maximum bite force (MBF) in adult subjects with different facial morphologies. MBF was measured by a portable occlusal force gauge and lateral cephalogram was used for evaluation of craniofacial morphology in 19 individuals (7 males and 12 females) with a mean age of 25.4 years (SD ± 4.3). The volunteers underwent gum chewing exercise for 5 min twice a day for 4 weeks. MBF was measured before (T1) and after the 4‐week exercise (T2). The facial morphology of the subjects was classified into the brachy (n = 7), mesio (n = 7), and dolicho (n = 5) facial types. In all three groups, exercise was associated with a significant increase in MBF, though the percent increase was highest in the dolicho facial type. We conclude that gum chewing exercise can improve masticatory performance, especially in individuals with dolicho facial morphology

    MRA Diagnosis of Down Syndrome Associated with Moyamoya Syndrome Presenting Multiple Cerebral Infarctions in a 1-year-old Girl

    Get PDF
    It is known that various complications are observed in patients with Down syndrome. We report a 1-year-old girl with Down syndrome who developed moyamoya syndrome presenting multiple cerebral infarction. Her chief complaints were recurrent convulsion and weakness on the left side of the body. Brain CT and MRI demonstrated multiple abnormal signals, and the lesion was diagnosed as multiple cerebral infarction. Since obstruction of the right anterior and middle cerebral arteries was observed by MRA, the patient was diagnosed with moyamoya syndrome. Moyamoya syndrome accompanied by Down syndrome advances in the early stage, and since it often occurs with cerebral infarction, the timing of its early diagnosis by MRA and caution of cerebral infarction are important. However, no guidelines for the control of moyamoya syndrome have been established in Down syndrome. Therefore, MRA should be performed in patients in whom moyamoya disease is suspected, because no useful method for the prevention of this complication disease has established

    Clustered Tonic Spasms Developed after Disappearance of Hypsarrythmia in West Syndrome

    Get PDF
    We report an infant case of West syndrome with clustered tonic spasms seen after the disappearance of hypsarrythmia. This time lag until the development of tonic spasms implies that their development is not directly related to hypsarrythmia. In other words, this clinical evidence suggests that the hypsarrythmia and tonic spasms did not directly originate from the same mechanism in West syndrome. In this report, we describe the patient\u27s demonstrable neuro-radiological imaging with CT, MRI, ^Tc-ECD SPECT, and EEG changes over her clinical course before and after low-dose ACTH therapy for West syndrome. In addition, the mechanisms of hypsarrythmia and infantile spasms are discussed with a literature review
    corecore